Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk of Venous Thromboembolism in Grade II-IV Gliomas as a Function of Molecular Subtype.

Neurology - 16 Feb 2021

Diaz Maria, Jo Jasmin, Smolkin Mark, Ratcliffe Sarah Jane, Schiff David

Abstract excerpt

OBJECTIVE: To determine the incidence of venous thromboembolism (VTE) in lower-grade gliomas (LGGs, WHO grades II-III) and to stratify the risk of VTE by molecular subtype in gliomas grade II-IV, we performed a retrospective review of a large cohort of patients with glioma. METHODS: We performed a retrospective analysis of a cohort of 635 adult patients with glioma with molecular testing seen at the University of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Glioma
Share to Incidence

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Neoplasm Grading

Share to Promoter Regions, Genetic

Share to Venous Thromboembolism

Source

Open in PubMed Open full text

Identifiers

PMID: 33361259
DOI: 10.1212/WNL.0000000000011414
PMCID: PMC8055337

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk of Venous Thromboembolism in Grade II-IV Gliomas as a Function of Molecular Subtype.PMID 33361259Read ↗

Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis.Semantic proximity Read ↗

Assessment of venous thromboembolism in adult diffuse-type gliomas: an experience of a quaternary center and a systematic reviewSemantic proximity Read ↗

Determining venous thromboembolism risk in patients with adult-type diffuse glioma.Semantic proximity Read ↗

Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort studySemantic proximity Read ↗

Association between IDH mutational status and tumor-associated epilepsy or venous thromboembolism in patients with grade II and III astrocytoma.Semantic proximity Read ↗

IDH mutation status and the development of venous thromboembolism in astrocytoma patients.Semantic proximity Read ↗

Mutant IDH1 and thrombosis in gliomas.Semantic proximity Read ↗

Combined analysis of clinical and laboratory markers to predict the risk of venous thromboembolism in patients with IDH1 wild-type glioblastoma.Semantic proximity Read ↗

Optimizing the Prediction of Venous Thromboembolis by a Risk Assessment Model in Patients with GlioblastomaSemantic proximity Read ↗

Cancer genetic profile and risk of thrombosis.Semantic proximity Read ↗

The role of germline and somatic mutations in predicting cancer-associated thrombosis: a narrative review.Semantic proximity Read ↗

Molecular determinants of thrombosis recurrence risk across venous thromboembolism subtypesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.